SlideShare ist ein Scribd-Unternehmen logo
1 von 17
Downloaden Sie, um offline zu lesen
Photo: Riccardo Venturi




                          Giornata	
  Mondiale	
  della	
  
                                Tubercolosi	
  
                              Milano,	
  14	
  March	
  2013	
  

                                           Dr	
  Mario	
  C	
  Raviglione	
  
                                           	
  	
  

                                           	
  
                                           Director	
  	
  
                                           Stop	
  TB	
  Department	
  
                                           	
  	
  
Overview	
  


               ü  Burden	
  of	
  TB,	
  TB/HIV,	
  
                   MDR-­‐TB	
  

               ü  Strategy	
  and	
  targets	
  
                   	
  
               ü  Impact	
  of	
  intervenEons,	
  
                   and	
  progress	
  in	
  control	
  
                   and	
  care	
  

               	
  
The	
  Global	
  Burden	
  of	
  TB	
  -­‐2011	
  

                                                    Estimated number                                        Estimated number
                                                         of cases                                               of deaths


         All	
  forms	
  of	
  TB	
                     8.7	
  million	
                                     	
  	
  	
  	
  1.4	
  million*	
  
                                                     (8.3–9.0	
  million)	
                                  (1.3–1.6	
  million)	
  

      HIV-­‐associated	
  TB	
                   	
  	
  1.1	
  million	
  (13%)	
                                 430,000	
  
                                                          	
  (1.0–1.2	
  million)	
                       (400,000–460,000)	
  

  MulFdrug-­‐resistant	
  TB	
                               630,000	
  	
                               Unknown,	
  but	
  
                                                       (460,000-­‐790,000)	
  
                                                        out	
  of	
  ~12	
  million	
  	
  
                                                                                                       probably	
  >	
  150,000	
  	
  
                                                        prevalent	
  TB	
  cases	
  

Source:	
  WHO	
  Global	
  Tuberculosis	
  Report	
  2012	
                                  *	
  Including	
  deaths	
  aUributed	
  to	
  HIV/TB	
  
Incidence	
  rates,	
  2011	
  




                                                                                                          0–24
                                                                                                          25–49
                                                                                                          50–149
                                                                                                          150–299
                                                                                                           ≥300
                                                                                                   Per	
  100	
  000	
  populaEon	
  
                                                                                                   	
  
 Highest	
  rates	
  in	
  Africa,	
  linked	
  to	
  high	
  rates	
  of	
  HIV	
  infecEon	
  
 ~80%	
  of	
  HIV+	
  TB	
  cases	
  in	
  Africa	
  
TB/HIV	
  co-­‐infecEon:	
  80%	
  of	
  burden	
  in	
  Africa	
  

ü  80%	
  of	
  all	
  TB/HIV	
  cases	
  are	
  in	
  Africa	
  

ü  TB	
  leading	
  cause	
  of	
  death	
  in	
  PLHIV	
  	
  

ü  ¼	
  	
  of	
  PLHIV	
  	
  worldwide	
  die	
  due	
  to	
  TB.	
  	
  

ü  PLHIV	
  infected	
  with	
  TB	
  20-­‐40	
  Emes	
  
     more	
  likely	
  to	
  develop	
  acEve	
  TB.	
  

ü  Untreated,	
  TB	
  in	
  PLHIV	
  leads	
  to	
  death	
  
     in	
  weeks	
  
EsEmated	
  number	
  of	
  MDR-­‐TB	
  Cases,	
  2011	
  
>60%	
  of	
  all	
  cases	
  are	
  in	
  5	
  countries	
  
                                                                                                                                                                                                                 Russian	
  FederaEon	
  
                                                                                                                                                                                                                       44,000	
  	
  
                                                                                                                                                                                                                  (14%	
  of	
  global	
  MDR	
  burden)	
  	
  




                                                                                                                                                                                                                                                            China	
  
                                                                                                                                                                                                                                                            61,000	
  
                                                                                                                                                                                                                                                   (20%	
  of	
  global	
  MDR	
  
                                                                                                South	
  Africa	
                                                                                                                                          burden)	
  	
  
                                                                                                   8,100	
  
                                                                                                      Based	
  on	
  old	
  	
  
                                                                                                      survey	
  data	
  


                                                                                                      Pakistan	
  
                                                                                                       10,000	
                                                               India	
                                   Philippines	
  
                                                                                                 (3%	
  of	
  global	
  MDR	
  
                                                                                                         burden)	
  	
                                                       66,000	
                                     11,000	
  
                                                                                                                                                                   (21%	
  of	
  global	
  MDR	
                           (4%	
  of	
  global	
  
                                                                                                                                                                           burden)	
  	
                                   MDR	
  burden)	
  	
  
The	
  boundaries	
  and	
  names	
  shown	
  and	
  the	
  designaFons	
  used	
  on	
  this	
  map	
  do	
  not	
  imply	
  the	
  expression	
  of	
  any	
  opinion	
  whatsoever	
  on	
  the	
  part	
  of	
  the	
  World	
  Health	
  OrganizaFon	
  concerning	
  
the	
  legal	
  status	
  of	
  any	
  country,	
  territory,	
  city	
  or	
  area	
  or	
  of	
  its	
  authoriFes,	
  or	
  concerning	
  the	
  delimitaFon	
  of	
  its	
  fronFers	
  or	
  boundaries.	
  	
  DoUed	
  lines	
  on	
  maps	
  represent	
  approximate	
  border	
  
                                                                                                               lines	
  for	
  which	
  there	
  may	
  not	
  yet	
  be	
  full	
  agreement.	
  	
  
                                                                                                                                ©	
  WHO	
  2012.	
  All	
  rights	
  reserved	
  
Who	
  carries	
  the	
  burden	
  of	
  tuberculosis?	
  
 …mostly,	
  the	
  most	
  vulnerable	
  
TB	
  spreads	
  in	
  poor,	
  crowded	
  &	
  poorly	
  
venElated	
  seangs	
  




                                                                 500,000	
  women	
  and	
  
                                                                 65,000	
  children	
  die	
  of	
   Migrants,	
  prisoners,	
  minoriEes,	
  
                                                                 TB	
  each	
  year;	
  10	
  million	
   refugees	
  face	
  risks,	
  discriminaEon	
  
                                                                 “TB”	
  orphans	
                        &	
  barriers	
  to	
  care	
  




TB	
  linked	
  to	
  HIV	
  infecEon,	
  malnutriEon,	
  
alcohol,	
  drug	
  and	
  tobacco	
  use,	
  diabetes	
  	
  
Francesco	
  I	
  had	
  tuberculosis!	
  




    …El Cardenal tiene una salud frágil, consecuencia de una tuberculosis
    que lo atacó cuando era un niño y le dejó secuelas: le falta la parte
    superior alveolar del pulmón derecho… Sin embargo, físicamente es
    fuerte. El mismo se esfuerza para no ser menos que los demás y practica
    natación…
The	
  global	
  burden	
  of	
  TB	
  in	
  2011:	
  	
  
women	
  &	
  children	
  
Estimated TB incidence rates, by country, 2010




                                                 TB cases
                                                 per 100 000

                                                               Estimated           Estimated
                                                    0–24
                                                    25–49
                                                    50–99
                                                    100–299
                                                    >=300
                                                               number of           number of
                                                    No estimate
                                                                 cases              deaths



       All forms of TB                                         2.9 million            500,000 *
         (in women)                                (range, 2.6–3.2 million)    (range, 400,000–600,000)



      All forms of TB                                             500,000            64,000*
     (Children <15 yr)                                     (470,000–510,000)   (range, 58,000–71,000)



 * excluding deaths among HIV+ people
The	
  global	
  response:	
  	
  
Stop	
  TB	
  Strategy	
  &	
  Global	
  Plan	
  
1.        Pursue	
  high-­‐quality	
  DOTS	
             To	
  save	
  lives,	
  prevent	
  suffering,	
  protect	
  the	
  
          expansion	
                                    vulnerable,	
  &	
  promote	
  human	
  rights	
  

2.        Address	
  TB-­‐HIV,	
  MDR-­‐TB,	
  
          and	
  needs	
  of	
  the	
  poor	
  and	
  
          vulnerable	
  

3.        Contribute	
  to	
  health	
  
          system	
  strengthening	
  

4. 	
     Engage	
  all	
  care	
  providers	
  

5.        Empower	
  people	
  with	
  TB	
  
          and	
  communiEes	
  

6. 	
     Enable	
  and	
  promote	
  
          research	
  
Global	
  Progress	
  on	
  impact	
  
                       ü  	
  51	
  million	
  paEents	
  
                           cured,	
  1995-­‐2011	
  

                       ü  	
  20	
  million	
  lives	
  saved	
  
                           since	
  1995	
  

                       ü  	
  	
  2015	
  MDG	
  target	
  on	
  
                            track:	
  global	
  TB	
  
                            incidence	
  rate	
  peaked	
  
                            in	
  early	
  2000s	
  
                            	
  
                       ü  	
  BUT,	
  TB	
  incidence	
  
                            declining	
  too	
  slowly,	
  	
  
                            1.4	
  million	
  people	
  sFll	
  
                            dying,	
  MDR-­‐TB	
  
                            response	
  slow,	
  gaps	
  in	
  
                            financing	
  
                       	
  
EsEmated	
  lives	
  saved	
  2005-­‐2010	
  through	
  
collaboraEve	
  TB/HIV	
  intervenEons	
  	
  




    CumulaFve	
  	
  2005-­‐10=	
  910,000	
  (800,000	
  –	
  1,100,000)	
  	
  	
  
What	
  are	
  the	
  challenges	
  in	
  2013	
  if	
  we	
  target	
  beher	
  
care,	
  control	
  and	
  ulEmately	
  “eliminaEon"?	
  

   1.  Funding	
  not	
  secure	
  at	
  system	
  and	
  individual	
  level:	
  TB	
  is	
  a	
  catastrophic	
  
       expenditure	
  for	
  the	
  poor	
  
       	
  
   2.  TB/HIV	
  major	
  impact	
  in	
  Africa,	
  especially	
  in	
  women	
  and	
  children	
  
       	
  
   3.  Weak	
  health	
  policies,	
  systems	
  and	
  services	
  
       	
  
   4.  Links	
  with	
  maternal	
  and	
  children	
  services	
  not	
  yet	
  a	
  rouEne	
  

   5.  Un-­‐engaged	
  non-­‐state	
  pracEEoners,	
  NGOs,	
  FBOs	
  and	
  communiEes	
  

   6.  MDR-­‐TB	
  care	
  and	
  cure	
  inadequate,	
  especially	
  among	
  PLHIV	
  

   7.  Social	
  and	
  economic	
  determinants	
  maintaining	
  TB	
  

   8.  Research	
  awakening	
  needed	
  for	
  new	
  diagnosEcs,	
  drugs	
  and	
  vaccines	
  
Challenge:	
  TB	
  as	
  a	
  cause	
  of	
  maternal	
  and	
  child	
  
morbidity	
  and	
  mortality	
  
ü  TB	
  causes	
  1-­‐16%	
  of	
  all	
  inferElity	
  and	
  15-­‐40%	
  of	
  tubal	
  inferElity	
  

ü  Facility	
  based	
  studies:	
  12-­‐14%	
  of	
  all	
  TB	
  	
  cases	
  are	
  in	
  children	
  

ü  TB	
  prevenEon	
  for	
  child	
  contacts	
  not	
  pracEced	
  
    	
  
ü  Studies	
  from	
  SS	
  Africa	
  and	
  India	
  showed:	
  	
  	
  
         –  TB	
  as	
  a	
  cause	
  of	
  all	
  maternal	
  mortality:	
  6-­‐15%	
  	
  
         –  TB	
  as	
  a	
  cause	
  of	
  indirect	
  maternal	
  mortality:	
  15-­‐34%	
  
References:	
  	
  
Khan	
  M	
  et	
  al,	
  AIDS	
  2001;	
  15:1857–63.	
  
Ahmed	
  Y	
  et	
  al,	
  Int	
  J	
  Tuberc	
  Lung	
  Dis	
  1999;	
  3:675–80.	
  
Panchabhai	
  TS	
  et	
  al,.	
  J	
  Postgrad	
  Med	
  2009;	
  55:8–11.	
  
Menendez	
  C	
  et	
  al.	
  PLoS	
  Med	
  2008;	
  5:e44.	
  
AcEon	
  for	
  MCH	
  services	
  
CUAMM	
  posiEon	
  paper	
  

                                                           …First	
  mothers	
  and	
  
                                                           children	
  (with	
  TB)….	
  
                                                           	
  
                                                           CUAMM	
  deciding	
  to	
  
                                                           get	
  engaged	
  at	
  all	
  
                                                           levels	
  in	
  the	
  fight	
  
                                                           against	
  TB,	
  as	
  there	
  
                                                           cannot	
  be	
  proper	
  
                                                           maternal	
  and	
  child	
  care	
  
                                                           in	
  Africa	
  without	
  
                                                           addressing	
  asserFvely	
  
Prepared	
  in	
  collabora:on	
  with	
  the	
  top	
  
                                                           TB	
  and	
  TB/HIV	
  
Italian	
  experts	
  in	
  TB	
                           	
  
Many	
  
  thanks	
  
 to	
  all	
  for	
  
choosing	
  to	
  	
  
Stop	
  TB!	
  

Weitere ähnliche Inhalte

Ähnlich wie PPT Raviglione "Stop TB in my lifetime -Giornata Mondiale della Tubercolosi"

07-Presentation1
07-Presentation107-Presentation1
07-Presentation1manish joya
 
Rntcp evaluation in dharwad district
Rntcp evaluation in dharwad district Rntcp evaluation in dharwad district
Rntcp evaluation in dharwad district abhishekgn
 
Cdc flu disease burden 2 17-18
Cdc flu disease burden 2 17-18Cdc flu disease burden 2 17-18
Cdc flu disease burden 2 17-18JA Larson
 
Healthcare Market in Egypt and it's Relation to Internet Growth
Healthcare Market in Egypt and it's Relation to Internet GrowthHealthcare Market in Egypt and it's Relation to Internet Growth
Healthcare Market in Egypt and it's Relation to Internet GrowthOsama ElKhair
 
DIAGNOSIS AND MANAGEMENT OF TUBERCULOSIS IN INDIA - CURRENT SCENARIO
DIAGNOSIS AND MANAGEMENT OF TUBERCULOSIS IN INDIA - CURRENT SCENARIODIAGNOSIS AND MANAGEMENT OF TUBERCULOSIS IN INDIA - CURRENT SCENARIO
DIAGNOSIS AND MANAGEMENT OF TUBERCULOSIS IN INDIA - CURRENT SCENARIOKatySam
 
PPT Matteelli "Epidemiologia della TB"
PPT Matteelli "Epidemiologia della TB"PPT Matteelli "Epidemiologia della TB"
PPT Matteelli "Epidemiologia della TB"StopTb Italia
 
TB in the workplace and beyond - Contribution of Occupational Health Services...
TB in the workplace and beyond - Contribution of Occupational Health Services...TB in the workplace and beyond - Contribution of Occupational Health Services...
TB in the workplace and beyond - Contribution of Occupational Health Services...Jean Jacques Bernatas
 
Challenges in Implementing Tobacco Dependence Treatment in Jordan and the Eas...
Challenges in Implementing Tobacco Dependence Treatment in Jordan and the Eas...Challenges in Implementing Tobacco Dependence Treatment in Jordan and the Eas...
Challenges in Implementing Tobacco Dependence Treatment in Jordan and the Eas...Global Bridges
 
Impact of pulmonary tuberculosis in hiv patients, retrospective study from ja...
Impact of pulmonary tuberculosis in hiv patients, retrospective study from ja...Impact of pulmonary tuberculosis in hiv patients, retrospective study from ja...
Impact of pulmonary tuberculosis in hiv patients, retrospective study from ja...Dr Nzasi Deppinair Mundabi
 
European approach - HA-REACT Joint Action as an exmple_eng
European approach - HA-REACT Joint Action as an exmple_engEuropean approach - HA-REACT Joint Action as an exmple_eng
European approach - HA-REACT Joint Action as an exmple_engTHL
 
Facilitor's guide for cv training draft1
Facilitor's guide for cv training  draft1Facilitor's guide for cv training  draft1
Facilitor's guide for cv training draft1Abhijit Dey
 
1.-Current-progress-towards-90-90-90-HIV-treatment-achievement-and-exploratio...
1.-Current-progress-towards-90-90-90-HIV-treatment-achievement-and-exploratio...1.-Current-progress-towards-90-90-90-HIV-treatment-achievement-and-exploratio...
1.-Current-progress-towards-90-90-90-HIV-treatment-achievement-and-exploratio...AMANUELMELAKU5
 
Effectiveness of tuberculosis screening among a high-risk population: recomme...
Effectiveness of tuberculosis screening among a high-risk population: recomme...Effectiveness of tuberculosis screening among a high-risk population: recomme...
Effectiveness of tuberculosis screening among a high-risk population: recomme...Георги Календеров
 

Ähnlich wie PPT Raviglione "Stop TB in my lifetime -Giornata Mondiale della Tubercolosi" (20)

Tuapr 2011 figures_web
Tuapr 2011 figures_webTuapr 2011 figures_web
Tuapr 2011 figures_web
 
07-Presentation1
07-Presentation107-Presentation1
07-Presentation1
 
Rntcp evaluation in dharwad district
Rntcp evaluation in dharwad district Rntcp evaluation in dharwad district
Rntcp evaluation in dharwad district
 
Cdc flu disease burden 2 17-18
Cdc flu disease burden 2 17-18Cdc flu disease burden 2 17-18
Cdc flu disease burden 2 17-18
 
Mena research priorities
Mena research prioritiesMena research priorities
Mena research priorities
 
Regional overview of HIV/AIDS in the Eastern Mediterranean Region, 2020
Regional overview of HIV/AIDS in the Eastern Mediterranean Region, 2020Regional overview of HIV/AIDS in the Eastern Mediterranean Region, 2020
Regional overview of HIV/AIDS in the Eastern Mediterranean Region, 2020
 
Healthcare Market in Egypt and it's Relation to Internet Growth
Healthcare Market in Egypt and it's Relation to Internet GrowthHealthcare Market in Egypt and it's Relation to Internet Growth
Healthcare Market in Egypt and it's Relation to Internet Growth
 
DIAGNOSIS AND MANAGEMENT OF TUBERCULOSIS IN INDIA - CURRENT SCENARIO
DIAGNOSIS AND MANAGEMENT OF TUBERCULOSIS IN INDIA - CURRENT SCENARIODIAGNOSIS AND MANAGEMENT OF TUBERCULOSIS IN INDIA - CURRENT SCENARIO
DIAGNOSIS AND MANAGEMENT OF TUBERCULOSIS IN INDIA - CURRENT SCENARIO
 
PPT Matteelli "Epidemiologia della TB"
PPT Matteelli "Epidemiologia della TB"PPT Matteelli "Epidemiologia della TB"
PPT Matteelli "Epidemiologia della TB"
 
TB in the workplace and beyond - Contribution of Occupational Health Services...
TB in the workplace and beyond - Contribution of Occupational Health Services...TB in the workplace and beyond - Contribution of Occupational Health Services...
TB in the workplace and beyond - Contribution of Occupational Health Services...
 
Challenges in Implementing Tobacco Dependence Treatment in Jordan and the Eas...
Challenges in Implementing Tobacco Dependence Treatment in Jordan and the Eas...Challenges in Implementing Tobacco Dependence Treatment in Jordan and the Eas...
Challenges in Implementing Tobacco Dependence Treatment in Jordan and the Eas...
 
Impact of pulmonary tuberculosis in hiv patients, retrospective study from ja...
Impact of pulmonary tuberculosis in hiv patients, retrospective study from ja...Impact of pulmonary tuberculosis in hiv patients, retrospective study from ja...
Impact of pulmonary tuberculosis in hiv patients, retrospective study from ja...
 
European approach - HA-REACT Joint Action as an exmple_eng
European approach - HA-REACT Joint Action as an exmple_engEuropean approach - HA-REACT Joint Action as an exmple_eng
European approach - HA-REACT Joint Action as an exmple_eng
 
Tuberculosis
TuberculosisTuberculosis
Tuberculosis
 
Facilitor's guide for cv training draft1
Facilitor's guide for cv training  draft1Facilitor's guide for cv training  draft1
Facilitor's guide for cv training draft1
 
1.-Current-progress-towards-90-90-90-HIV-treatment-achievement-and-exploratio...
1.-Current-progress-towards-90-90-90-HIV-treatment-achievement-and-exploratio...1.-Current-progress-towards-90-90-90-HIV-treatment-achievement-and-exploratio...
1.-Current-progress-towards-90-90-90-HIV-treatment-achievement-and-exploratio...
 
Wireless Health
Wireless HealthWireless Health
Wireless Health
 
Effectiveness of tuberculosis screening among a high-risk population: recomme...
Effectiveness of tuberculosis screening among a high-risk population: recomme...Effectiveness of tuberculosis screening among a high-risk population: recomme...
Effectiveness of tuberculosis screening among a high-risk population: recomme...
 
TB situation in the EU and EEA countries, 2014
TB situation in the EU and EEA countries, 2014TB situation in the EU and EEA countries, 2014
TB situation in the EU and EEA countries, 2014
 
Status of PrEP implementation in Europe (Nov 2019)
Status of PrEP implementation in Europe (Nov 2019)Status of PrEP implementation in Europe (Nov 2019)
Status of PrEP implementation in Europe (Nov 2019)
 

Mehr von StopTb Italia

PPT Messa "Un tributo pagato dall'arte"
PPT Messa "Un tributo pagato dall'arte"PPT Messa "Un tributo pagato dall'arte"
PPT Messa "Un tributo pagato dall'arte"StopTb Italia
 
PPT Rizzardini "HAART, sostenibilità di un miracolo"
PPT Rizzardini "HAART, sostenibilità di un miracolo"PPT Rizzardini "HAART, sostenibilità di un miracolo"
PPT Rizzardini "HAART, sostenibilità di un miracolo"StopTb Italia
 
PPT Ranieri "HIV e TB in carcere"
PPT Ranieri "HIV e TB in carcere"PPT Ranieri "HIV e TB in carcere"
PPT Ranieri "HIV e TB in carcere"StopTb Italia
 
PPT Fiorentini "TB tra ospedale e territorio"
PPT Fiorentini "TB tra ospedale e territorio"PPT Fiorentini "TB tra ospedale e territorio"
PPT Fiorentini "TB tra ospedale e territorio"StopTb Italia
 
PPT Rusconi "Le multiresistenze dell'HIV/AIDS"
PPT Rusconi "Le multiresistenze dell'HIV/AIDS"PPT Rusconi "Le multiresistenze dell'HIV/AIDS"
PPT Rusconi "Le multiresistenze dell'HIV/AIDS"StopTb Italia
 
PPT Besozzi "Le multiresistenze della TB"
PPT Besozzi "Le multiresistenze della TB"PPT Besozzi "Le multiresistenze della TB"
PPT Besozzi "Le multiresistenze della TB"StopTb Italia
 
PPT Motta "La farmacologia clinica nella infezione e coinfezione TB/HIV"
PPT Motta "La farmacologia clinica nella infezione e coinfezione TB/HIV"PPT Motta "La farmacologia clinica nella infezione e coinfezione TB/HIV"
PPT Motta "La farmacologia clinica nella infezione e coinfezione TB/HIV"StopTb Italia
 
PPT Concia "Localizzazioni extrapolmonari nella coinfezione"
PPT Concia "Localizzazioni extrapolmonari nella coinfezione"PPT Concia "Localizzazioni extrapolmonari nella coinfezione"
PPT Concia "Localizzazioni extrapolmonari nella coinfezione"StopTb Italia
 
PPT Lapadula "Clinica e terapia in TB/HIV"
PPT Lapadula "Clinica e terapia in TB/HIV"PPT Lapadula "Clinica e terapia in TB/HIV"
PPT Lapadula "Clinica e terapia in TB/HIV"StopTb Italia
 
PPT Bonora "Clinica e terapia dell'HIV"
PPT Bonora "Clinica e terapia dell'HIV"PPT Bonora "Clinica e terapia dell'HIV"
PPT Bonora "Clinica e terapia dell'HIV"StopTb Italia
 
PPT Cirillo "La diagnosi di tubercolosi"
PPT Cirillo "La diagnosi di tubercolosi"PPT Cirillo "La diagnosi di tubercolosi"
PPT Cirillo "La diagnosi di tubercolosi"StopTb Italia
 
PPT Gori "Immunologia TB/HIV"
PPT Gori "Immunologia TB/HIV"PPT Gori "Immunologia TB/HIV"
PPT Gori "Immunologia TB/HIV"StopTb Italia
 
PPT Castelli "Dall'HIV all'AIDS fino alla coinfezione: una diagnosi difficile?"
PPT Castelli "Dall'HIV all'AIDS fino alla coinfezione: una diagnosi difficile?"PPT Castelli "Dall'HIV all'AIDS fino alla coinfezione: una diagnosi difficile?"
PPT Castelli "Dall'HIV all'AIDS fino alla coinfezione: una diagnosi difficile?"StopTb Italia
 
PPT Bocchino "Diagnosi dell'infezione tubercolare"
PPT Bocchino "Diagnosi dell'infezione tubercolare"PPT Bocchino "Diagnosi dell'infezione tubercolare"
PPT Bocchino "Diagnosi dell'infezione tubercolare"StopTb Italia
 
PPT Angarano "Storia naturale dell'HIV"
PPT Angarano "Storia naturale dell'HIV"PPT Angarano "Storia naturale dell'HIV"
PPT Angarano "Storia naturale dell'HIV"StopTb Italia
 
PPT Casali "Storia naturale della TB"
PPT Casali "Storia naturale della TB"PPT Casali "Storia naturale della TB"
PPT Casali "Storia naturale della TB"StopTb Italia
 
PPT Girardi "Epidemiologia della confezione TB-HIV"
PPT Girardi "Epidemiologia della confezione TB-HIV"PPT Girardi "Epidemiologia della confezione TB-HIV"
PPT Girardi "Epidemiologia della confezione TB-HIV"StopTb Italia
 
PPT Pezzotti "Epidemiologia dell'HIV"
PPT Pezzotti "Epidemiologia dell'HIV"PPT Pezzotti "Epidemiologia dell'HIV"
PPT Pezzotti "Epidemiologia dell'HIV"StopTb Italia
 
PPT Galli "Storia dell'HIV"
PPT Galli "Storia dell'HIV"PPT Galli "Storia dell'HIV"
PPT Galli "Storia dell'HIV"StopTb Italia
 

Mehr von StopTb Italia (20)

PPT Messa "Un tributo pagato dall'arte"
PPT Messa "Un tributo pagato dall'arte"PPT Messa "Un tributo pagato dall'arte"
PPT Messa "Un tributo pagato dall'arte"
 
PPT Rizzardini "HAART, sostenibilità di un miracolo"
PPT Rizzardini "HAART, sostenibilità di un miracolo"PPT Rizzardini "HAART, sostenibilità di un miracolo"
PPT Rizzardini "HAART, sostenibilità di un miracolo"
 
PPT Ranieri "HIV e TB in carcere"
PPT Ranieri "HIV e TB in carcere"PPT Ranieri "HIV e TB in carcere"
PPT Ranieri "HIV e TB in carcere"
 
PPT Fiorentini "TB tra ospedale e territorio"
PPT Fiorentini "TB tra ospedale e territorio"PPT Fiorentini "TB tra ospedale e territorio"
PPT Fiorentini "TB tra ospedale e territorio"
 
PPT Rusconi "Le multiresistenze dell'HIV/AIDS"
PPT Rusconi "Le multiresistenze dell'HIV/AIDS"PPT Rusconi "Le multiresistenze dell'HIV/AIDS"
PPT Rusconi "Le multiresistenze dell'HIV/AIDS"
 
PPT Besozzi "Le multiresistenze della TB"
PPT Besozzi "Le multiresistenze della TB"PPT Besozzi "Le multiresistenze della TB"
PPT Besozzi "Le multiresistenze della TB"
 
PPT Motta "La farmacologia clinica nella infezione e coinfezione TB/HIV"
PPT Motta "La farmacologia clinica nella infezione e coinfezione TB/HIV"PPT Motta "La farmacologia clinica nella infezione e coinfezione TB/HIV"
PPT Motta "La farmacologia clinica nella infezione e coinfezione TB/HIV"
 
PPT Concia "Localizzazioni extrapolmonari nella coinfezione"
PPT Concia "Localizzazioni extrapolmonari nella coinfezione"PPT Concia "Localizzazioni extrapolmonari nella coinfezione"
PPT Concia "Localizzazioni extrapolmonari nella coinfezione"
 
PPT Lapadula "Clinica e terapia in TB/HIV"
PPT Lapadula "Clinica e terapia in TB/HIV"PPT Lapadula "Clinica e terapia in TB/HIV"
PPT Lapadula "Clinica e terapia in TB/HIV"
 
PPT Bonora "Clinica e terapia dell'HIV"
PPT Bonora "Clinica e terapia dell'HIV"PPT Bonora "Clinica e terapia dell'HIV"
PPT Bonora "Clinica e terapia dell'HIV"
 
PPT Casali
PPT CasaliPPT Casali
PPT Casali
 
PPT Cirillo "La diagnosi di tubercolosi"
PPT Cirillo "La diagnosi di tubercolosi"PPT Cirillo "La diagnosi di tubercolosi"
PPT Cirillo "La diagnosi di tubercolosi"
 
PPT Gori "Immunologia TB/HIV"
PPT Gori "Immunologia TB/HIV"PPT Gori "Immunologia TB/HIV"
PPT Gori "Immunologia TB/HIV"
 
PPT Castelli "Dall'HIV all'AIDS fino alla coinfezione: una diagnosi difficile?"
PPT Castelli "Dall'HIV all'AIDS fino alla coinfezione: una diagnosi difficile?"PPT Castelli "Dall'HIV all'AIDS fino alla coinfezione: una diagnosi difficile?"
PPT Castelli "Dall'HIV all'AIDS fino alla coinfezione: una diagnosi difficile?"
 
PPT Bocchino "Diagnosi dell'infezione tubercolare"
PPT Bocchino "Diagnosi dell'infezione tubercolare"PPT Bocchino "Diagnosi dell'infezione tubercolare"
PPT Bocchino "Diagnosi dell'infezione tubercolare"
 
PPT Angarano "Storia naturale dell'HIV"
PPT Angarano "Storia naturale dell'HIV"PPT Angarano "Storia naturale dell'HIV"
PPT Angarano "Storia naturale dell'HIV"
 
PPT Casali "Storia naturale della TB"
PPT Casali "Storia naturale della TB"PPT Casali "Storia naturale della TB"
PPT Casali "Storia naturale della TB"
 
PPT Girardi "Epidemiologia della confezione TB-HIV"
PPT Girardi "Epidemiologia della confezione TB-HIV"PPT Girardi "Epidemiologia della confezione TB-HIV"
PPT Girardi "Epidemiologia della confezione TB-HIV"
 
PPT Pezzotti "Epidemiologia dell'HIV"
PPT Pezzotti "Epidemiologia dell'HIV"PPT Pezzotti "Epidemiologia dell'HIV"
PPT Pezzotti "Epidemiologia dell'HIV"
 
PPT Galli "Storia dell'HIV"
PPT Galli "Storia dell'HIV"PPT Galli "Storia dell'HIV"
PPT Galli "Storia dell'HIV"
 

PPT Raviglione "Stop TB in my lifetime -Giornata Mondiale della Tubercolosi"

  • 1. Photo: Riccardo Venturi Giornata  Mondiale  della   Tubercolosi   Milano,  14  March  2013   Dr  Mario  C  Raviglione         Director     Stop  TB  Department      
  • 2. Overview   ü  Burden  of  TB,  TB/HIV,   MDR-­‐TB   ü  Strategy  and  targets     ü  Impact  of  intervenEons,   and  progress  in  control   and  care    
  • 3. The  Global  Burden  of  TB  -­‐2011   Estimated number Estimated number of cases of deaths All  forms  of  TB   8.7  million          1.4  million*   (8.3–9.0  million)   (1.3–1.6  million)   HIV-­‐associated  TB      1.1  million  (13%)   430,000    (1.0–1.2  million)   (400,000–460,000)   MulFdrug-­‐resistant  TB   630,000     Unknown,  but   (460,000-­‐790,000)   out  of  ~12  million     probably  >  150,000     prevalent  TB  cases   Source:  WHO  Global  Tuberculosis  Report  2012   *  Including  deaths  aUributed  to  HIV/TB  
  • 4. Incidence  rates,  2011   0–24 25–49 50–149 150–299 ≥300 Per  100  000  populaEon     Highest  rates  in  Africa,  linked  to  high  rates  of  HIV  infecEon   ~80%  of  HIV+  TB  cases  in  Africa  
  • 5. TB/HIV  co-­‐infecEon:  80%  of  burden  in  Africa   ü  80%  of  all  TB/HIV  cases  are  in  Africa   ü  TB  leading  cause  of  death  in  PLHIV     ü  ¼    of  PLHIV    worldwide  die  due  to  TB.     ü  PLHIV  infected  with  TB  20-­‐40  Emes   more  likely  to  develop  acEve  TB.   ü  Untreated,  TB  in  PLHIV  leads  to  death   in  weeks  
  • 6. EsEmated  number  of  MDR-­‐TB  Cases,  2011   >60%  of  all  cases  are  in  5  countries   Russian  FederaEon   44,000     (14%  of  global  MDR  burden)     China   61,000   (20%  of  global  MDR   South  Africa   burden)     8,100   Based  on  old     survey  data   Pakistan   10,000   India   Philippines   (3%  of  global  MDR   burden)     66,000   11,000   (21%  of  global  MDR   (4%  of  global   burden)     MDR  burden)     The  boundaries  and  names  shown  and  the  designaFons  used  on  this  map  do  not  imply  the  expression  of  any  opinion  whatsoever  on  the  part  of  the  World  Health  OrganizaFon  concerning   the  legal  status  of  any  country,  territory,  city  or  area  or  of  its  authoriFes,  or  concerning  the  delimitaFon  of  its  fronFers  or  boundaries.    DoUed  lines  on  maps  represent  approximate  border   lines  for  which  there  may  not  yet  be  full  agreement.     ©  WHO  2012.  All  rights  reserved  
  • 7. Who  carries  the  burden  of  tuberculosis?   …mostly,  the  most  vulnerable   TB  spreads  in  poor,  crowded  &  poorly   venElated  seangs   500,000  women  and   65,000  children  die  of   Migrants,  prisoners,  minoriEes,   TB  each  year;  10  million   refugees  face  risks,  discriminaEon   “TB”  orphans   &  barriers  to  care   TB  linked  to  HIV  infecEon,  malnutriEon,   alcohol,  drug  and  tobacco  use,  diabetes    
  • 8. Francesco  I  had  tuberculosis!   …El Cardenal tiene una salud frágil, consecuencia de una tuberculosis que lo atacó cuando era un niño y le dejó secuelas: le falta la parte superior alveolar del pulmón derecho… Sin embargo, físicamente es fuerte. El mismo se esfuerza para no ser menos que los demás y practica natación…
  • 9. The  global  burden  of  TB  in  2011:     women  &  children   Estimated TB incidence rates, by country, 2010 TB cases per 100 000 Estimated Estimated 0–24 25–49 50–99 100–299 >=300 number of number of No estimate cases deaths All forms of TB 2.9 million 500,000 * (in women) (range, 2.6–3.2 million) (range, 400,000–600,000) All forms of TB 500,000 64,000* (Children <15 yr) (470,000–510,000) (range, 58,000–71,000) * excluding deaths among HIV+ people
  • 10. The  global  response:     Stop  TB  Strategy  &  Global  Plan   1.  Pursue  high-­‐quality  DOTS   To  save  lives,  prevent  suffering,  protect  the   expansion   vulnerable,  &  promote  human  rights   2.  Address  TB-­‐HIV,  MDR-­‐TB,   and  needs  of  the  poor  and   vulnerable   3.  Contribute  to  health   system  strengthening   4.    Engage  all  care  providers   5.  Empower  people  with  TB   and  communiEes   6.    Enable  and  promote   research  
  • 11. Global  Progress  on  impact   ü   51  million  paEents   cured,  1995-­‐2011   ü   20  million  lives  saved   since  1995   ü     2015  MDG  target  on   track:  global  TB   incidence  rate  peaked   in  early  2000s     ü   BUT,  TB  incidence   declining  too  slowly,     1.4  million  people  sFll   dying,  MDR-­‐TB   response  slow,  gaps  in   financing    
  • 12. EsEmated  lives  saved  2005-­‐2010  through   collaboraEve  TB/HIV  intervenEons     CumulaFve    2005-­‐10=  910,000  (800,000  –  1,100,000)      
  • 13. What  are  the  challenges  in  2013  if  we  target  beher   care,  control  and  ulEmately  “eliminaEon"?   1.  Funding  not  secure  at  system  and  individual  level:  TB  is  a  catastrophic   expenditure  for  the  poor     2.  TB/HIV  major  impact  in  Africa,  especially  in  women  and  children     3.  Weak  health  policies,  systems  and  services     4.  Links  with  maternal  and  children  services  not  yet  a  rouEne   5.  Un-­‐engaged  non-­‐state  pracEEoners,  NGOs,  FBOs  and  communiEes   6.  MDR-­‐TB  care  and  cure  inadequate,  especially  among  PLHIV   7.  Social  and  economic  determinants  maintaining  TB   8.  Research  awakening  needed  for  new  diagnosEcs,  drugs  and  vaccines  
  • 14. Challenge:  TB  as  a  cause  of  maternal  and  child   morbidity  and  mortality   ü  TB  causes  1-­‐16%  of  all  inferElity  and  15-­‐40%  of  tubal  inferElity   ü  Facility  based  studies:  12-­‐14%  of  all  TB    cases  are  in  children   ü  TB  prevenEon  for  child  contacts  not  pracEced     ü  Studies  from  SS  Africa  and  India  showed:       –  TB  as  a  cause  of  all  maternal  mortality:  6-­‐15%     –  TB  as  a  cause  of  indirect  maternal  mortality:  15-­‐34%   References:     Khan  M  et  al,  AIDS  2001;  15:1857–63.   Ahmed  Y  et  al,  Int  J  Tuberc  Lung  Dis  1999;  3:675–80.   Panchabhai  TS  et  al,.  J  Postgrad  Med  2009;  55:8–11.   Menendez  C  et  al.  PLoS  Med  2008;  5:e44.  
  • 15. AcEon  for  MCH  services  
  • 16. CUAMM  posiEon  paper   …First  mothers  and   children  (with  TB)….     CUAMM  deciding  to   get  engaged  at  all   levels  in  the  fight   against  TB,  as  there   cannot  be  proper   maternal  and  child  care   in  Africa  without   addressing  asserFvely   Prepared  in  collabora:on  with  the  top   TB  and  TB/HIV   Italian  experts  in  TB    
  • 17. Many   thanks   to  all  for   choosing  to     Stop  TB!